It doesn’t matter who referred what and / or when they did it... the only thing that matters is that DECN never had a Covid product and still doesn’t. You can’t sell what you don’t have, nor can you distribute it.
Berman looks to be angling for more serious charges to be brought by the SEC. Not very smart.
(1)
(3)
Decision Diagnostics Corp (DECN) Stock Research Links